Overview First Line Chemotherapy for Advanced Cancer Status: Terminated Trial end date: 2016-02-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine whether albumine-bounded paclitaxel plus S-1 are effective in the treatment of advanced gastric or gastroesophageal junction adenocarcinoma. Phase: Phase 2 Details Lead Sponsor: Chinese Academy of Medical SciencesTreatments: Albumin-Bound PaclitaxelPaclitaxel